Events
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/03/Rectangle-35.jpg)
Vivet presenting at ARM 2019 Cell & Gene Meeting on the Med in Barcelona
Jean-Philippe Combal, Vivet CEO, will be attending a panel
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/asgct-logo-2019.png)
Vivet Therapeutics Announces 2 Abstracts Accepted For Oral Presentation At 2019 ASGCT
Paris, France, April 24, 2019 – Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing gene therapy treatments
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/EASL-2019.jpg)
VIVET PRESENTING LEAD PRODUCT, VTX-801, AND PFIC INDICATION VTX-803, AT 2019 INTERNATIONAL LIVER CONGRESS
Vivet Therapeutics will be making a presentation on its lead product
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/GT-for-RD_2019.png)
VIVET ATTENDING 3RD ANNUAL GENE THERAPY FOR RARE DISORDERS CONFERENCE IN BOSTON
Jean-Philippe Combal, Vivet Therapeutics’ CEO, will be attending the 3rd Annual Gene Therapy for Rare Disorders conference in Boston (March 26-28 2019).
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/BioProcessingSummit-EU_2019_long-768x384.jpg)
Vivet presenting during the 2019 Bioprocessing Summit Europe in Lisbon
Vivet Therapeutics’ CEO, Jean-Philippe Combal
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/csm_dia_europe_2019-1.jpg)
Vivet attending DIA Europe 2019 in Vienna on February 5-7
Anne Douar, Chief Development Officer of Vivet Therapeutics
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/JP-Morgan-2019-Healthcare-Conference1-768x228.jpg)
VIVET WILL BE AT THE 37TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Jean-Philippe Combal, Vivet Therapeutics’ CEO
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/Evercore-ISI-Copie1.jpg)
Vivet presenting at 2018 Evercore ISI HEALTHCONx in Boston
Vivet Therapeutics CEO, Jean-Philippe Combal
![](https://www.vivet-therapeutics.com/wp-content/uploads/2020/11/Jefferies-large.png)
VIVET ATTENDING JEFFERIES 2018 LONDON HEALTHCARE CONFERENCE
Jean-Philippe Combal, Vivet Therapeutics’ CEO, and Thomas Daniel, BD Director, will be hosting 1×1 meetings during Jefferies 2018 London Healthcare Conference on…
![](https://www.vivet-therapeutics.com/wp-content/uploads/2022/05/HW170712-Gene-Therapy-Europe-logo_website-e1500475734248.png)
VIVET PRESENTING DURING 2018 GENE THERAPY FOR RARE DISORDERS EUROPE CONFERENCE IN LONDON
Anne Douar, Chief Development Officer of Vivet Therapeutics